Clinical Trial Update: Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial [Phase 2, Phase 3]

View source ↗

Summary

A pivotal Phase 2/3 trial evaluating the Jarvik 2000 Heart LVAD as a bridge to heart transplantation for heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Jarvik 2000 Heart

Snippet

Sponsor: Jarvik Heart, Inc. | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED